FAM90A6P: A Potential Drug Target and Biomarker for Family with Sequence Similarity 90 Member A6

Target Name: FAM90A6P

NCBI ID: G389618

FAM90A6P

Other Name(s): family with sequence similarity 90 member A6, pseudogene | Family with sequence similarity 90, member A6, pseudogene

FAM90A6P: A Potential Drug Target and Biomarker for Family with Sequence Similarity 90 Member A6

Introduction

FAM90A6P is a gene located on chromosome 16q22. It is a member of the FAM90 gene family, which encodes proteins involved in various cellular processes, including DNA replication, repair, and splicing. Recent studies have shown that FAM90A6P is up-regulated in many tumors and is closely related to the prognosis of various cancers. This makes FAM90A6P a research subject that has attracted much attention. This article will discuss the biological function, expression pattern and role of FAM90A6P in tumors, with a view to providing useful enlightenment for related research.

Biological functions of FAM90A6P

FAM90A6P is a protein composed of 90 amino acids with a molecular weight of 11.1 kDa. FAM90A6P mainly participates in the DNA damage repair process in cells. In the process of DNA double-strand damage repair, the main function of FAM90A6P is to help cells perform DNA repair. The amino acid sequence of FAM90A6P shows that it has the following biological functions:

1. Repair blunt-end damage to DNA double strands: The conserved amino acids in FAM90A6P include ALA/VAL, ASN/FSN, ARG/GSN and TYR/TYR, etc. These amino acids play a key role in the DNA double-strand repair process, helping to guide biomolecules such as DNA polymerase in the correct direction for repair.

2. Repair blunt-end damage to DNA double strands: The conserved amino acids in FAM90A6P include ALA/VAL, ASN/FSN, ARG/GSN and TYR/TYR, etc. These amino acids play a key role in the DNA double-strand repair process, helping to guide biomolecules such as DNA polymerase in the correct direction for repair.

3. Participate in the repair process of DNA damage: The conserved amino acids in FAM90A6P include GLN/ALC, SPT/ASP, HTT/YYY and hkg/kgd, etc. These amino acids may play a key role in the repair process of DNA damage.

4. Participate in the repair process of DNA damage: The conserved amino acids in FAM90A6P include GLN/ALC, SPT/ASP, HTT/YYY and hkg/kgd, etc. These amino acids may play a key role in the repair process of DNA damage.

expression pattern

The expression of FAM90A6P in various tissues and tumors has been well studied. Based on expression pattern data, FAM90A6P expression levels vary in various tissues and tumors.

1. Expression in tumors: The expression levels of FAM90A6P vary in various tumor tissues. For example, in lung cancer tissues, the expression level of FAM90A6P is significantly higher than that in other tissues.

2. Expression in different types of tumors: The expression levels of FAM90A6P also vary in many different types of tumor tissues. For example, in squamous cell carcinoma and breast cancer tissues, the expression level of FAM90A6P is significantly higher than that in other tissues.

3. The relationship between FAM90A6P expression level and tumor prognosis: Increased FAM90A6P expression level is associated with poor prognosis of tumor patients. For example, in lung cancer patients, elevated FAM90A6P expression levels were significantly associated with shortened overall survival.

role in tumors

The role of FAM90A6P in tumors has been well studied. Research suggests that FAM90A6P鈥檚 roles in tumors may include:

1. Participate in the DNA damage repair process: The role of FAM90A6P in tumors may be related to DNA

Protein Name: Family With Sequence Similarity 90 Member A6, Pseudogene

The "FAM90A6P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAM90A6P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets